Cancer Prevention II
Springer Berlin (Verlag)
978-3-540-69296-6 (ISBN)
Cancer Prevention and Health Politics.- Do We Make Optimal Use of the Potential of Cancer Prevention?.- Predictors of Successful Cancer Prevention Programs.- Cancer Prevenpinon in the Developing World: Mission Impossible?.- Is Cancer Prevention Ever Going to Be Profitable?.- Cancer Prevention: The Scientific-Epidemiological Base.- Energy Metabolism, Cancer Risk, and Cancer Prevention.- Promises and Limitations of Biomarkers.- Cancer Prevention, Tobacco and Nutrition.- The EPIC Study: An Update.- Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype..- Retinoids and Breast Cancer Prevention.- Cancer Prevention, Genetics and Vaccines.- Cancer Prevention by Vaccination Against Hepatitis B.- Cancer Prevention and Target Organs I: Breast Cancer.- Energy Restriction for Breast Cancer Prevention.- The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer.- Prevention of ER-Negative Breast Cancer.- EHxoorgmeonnoeuss, aMnadmEmndooggraepnhoiucs Density and Breast Cancer Risk: Can Mammographic Density Be Considered an Intermediate Marker of Risk?.- Cancer Prevention and Target Organs II: Cancer of the Digestive Tract.- Chemoprevention of Oesophageal Cancer and the AspECT Trial.- Cancer Prevention and Target Organs III: Prostate Cancer.- Review of Diagnostic Markers for Prostate Cancer 16.- Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention.- Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studies.- Cancer Prevention and Target Organs III: Prostate Cancer.- Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids.- Aspirin and NSAIDs in Cancer Prevention: Attempts at an International Consensus.- Pharmacologic Effects of NSAIDs and Implications for the Risks and Benefits of Long-Term Prophylactic Use of Aspirin to Prevent Cancer.- Aspirin and NSAIDs for the Prevention of Colorectal Cancer.- Aspirin and Cancer Risk: A Summary Review to 2007.
Erscheint lt. Verlag | 10.12.2008 |
---|---|
Reihe/Serie | Recent Results in Cancer Research |
Zusatzinfo | XX, 252 p. 28 illus., 14 illus. in color. |
Verlagsort | Berlin |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 576 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Schlagworte | cancer prevention • chemoprevention • ER-negative breast cancer • Krebs (Krankheit) • Krebs (Krankheit) / Karzinom • prevention • Prevention of breast cancer • Primary prevention |
ISBN-10 | 3-540-69296-7 / 3540692967 |
ISBN-13 | 978-3-540-69296-6 / 9783540692966 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich